Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis

Nature Medicine

Volumn 11, Issue 3, 2005, Pages 320-327

  Lam, Tony K T ^a   Pocai, Alessandro ^a   Gutierrez Juarez, Roger ^a   Obici, Silvana ^a   Bryan, Joseph ^b   Aguilar Bryan, Lydia ^b   Schwartz, Gary J ^a   Rossetti, Luciano ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; FATTY ACID; GLIBENCLAMIDE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE; INSULIN; LONG CHAIN FATTY ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; OLEIC ACID; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; TRIACSIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTERIFICATION; FATTY ACID BLOOD LEVEL; GENE DELETION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE INFUSION; GLYCOGENOLYSIS; HYPERLIPIDEMIA; HYPOTHALAMUS; LIPID DIET; LIPID METABOLISM; LIVER METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; VAGOTOMY;

ANIMALS; COENZYME A LIGASES; DIABETES MELLITUS, TYPE 2; DIETARY FATS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE-6-PHOSPHATASE; GLYBURIDE; HOMEOSTASIS; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; LIVER; MALE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, SPRAGUE-DAWLEY; TRIAZENES; VAGOTOMY;

EID: 16244388931     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1201     Document Type: Article

References (49)

1. Taylor, S.I. Deconstructing type 2 diabetes. Cell 97, 9-12 (1999).
2. McGarry, J.D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258, 766-770 (1992).
3. McGarry, J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51, 7-18 (2002).
4. Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46, 3-10 (1997).
5. Shulman, G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest 106, 171-176 (2000).
6. Lam, T.K. et al. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am. J. Physiol. Endocrinol. Metab. 284, E863-E873 (2003).
7. Boden, G., Chen, X., Ruiz, J., White, J.V. & Rossetti, L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93, 2438-2446 (1994).
8. Lam, T.K., van de Werve, G. & Giacca, A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am. J. Physiol. Endocrinol. Metab. 284, E281-E290 (2003).
9. Rebrin, K., Steil, G.M., Mittelman, S.D. & Bergman, R.N. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J. Clin. Invest. 98, 741-749 (1996).
10. Sindelar, D.K. et al. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabeteses, 187-196 (1997).
11. Chu, C.A. et al. Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs. Am. J. Physiol. Endocrinol. Metab. 282, E402-E411 (2002).
12. Chen, X., Iqbal, N. & Boden, G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J. Clin. Invest. 103, 365-372 (1999).
13. Boden, G., Chen, X., Capulong, E. & Mozzoli, M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50, 810-816 (2001).
14. Miller, J.C., Gnaedinger, J.M. & Rapoport, S.I. Utilization of plasma fatty acid in rat brain: distribution of [14C]palmitate between oxidative and synthetic pathways. J. Neurochem. 49, 1507-1514 (1987).
15. Loftus, T.M. et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379-2381 (2000).
16. Obici, S. et al. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51, 271-275 (2002).
17. Obici, S., Feng, Z., Arduini, A., Conti, R. & Rossetti, L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat. Med. 9, 756-761 (2003).
18. Obici, S., Zhang, B.B., Karkanias, G. & Rossetti, L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8, 1376-1382 (2002).
19. Matsuhisa, M. et al. Important role of the hepatic vagus nerve in glucose uptake and production by the liver. Metabolism 49, 11-16 (2000).
20. Moore, M.C. et al. Effect of hepatic nerves on disposition of an intraduodenal glucose load. Am. J. Physiol 265, E487-E496 (1993).
21. Xue, C. et al. Isolated hepatic cholinergic denervation impairs glucose and glycogen metabolism. J. Surg. Res. 90, 19-25 (2000).
22. Aguilar-Bryan, L. et al. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268, 423-426 (1995).
23. Aguilar-Bryan, L. & Bryan, J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr. Rev. 20, 101-135 (1999).
24. Seino, S. & Miki, T. Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog. Biophys. Mol. Biol. 81, 133-176 (2003).
25. Inagaki, N. et al. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron 16, 1011-1017 (1996).
26. Branstrom, R., Corkey, B.E., Berggren, P.O. & Larsson, O. Evidence for a unique long chain acyl-CoA ester binding site on the ATP-regulated potassium channel in mouse pancreatic beta cells. J. Biol. Chem. 272, 17390-17394 (1997).
27. Gribble, F.M., Proks, P., Corkey, B.E. & Ashcroft, F.M. Mechanism of cloned ATP-sensitive potassium channel activation by oleoyl-CoA. J. Biol. Chem. 273, 26383-26387 (1998).
28. Morgan, K., Obici, S. & Rossetti, L. Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J. Biol. Chem. 279, 31139-31148 (2004).
29. Wang, J. et al. Overfeeding rapidly induces leptin and insulin resistance. Diabetes 50, 2786-2791 (2001).
30. Flier, J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116, 337-350 (2004).
31. Wojtczak, A.B., Walajtys-Rode, E.I. & Geelen, M.J. Interrelations between ureogenesis and gluconeogenesis in isolated hepatocytes. The role of antion transport and the competition for energy. Biochem. J. 170, 379-385 (1978).
32. Williamson, J.R., Kreisberg, R.A. & Felts, P.W. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc. Natl. Acad. Sci. USA 56, 247-254 (1966).
33. Clore, J.N., Glickman, P.S., Nestler, J.E. & Blackard, W.G. In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans, Am. J. Physiol. 261, E425-E429 (1991).
34. Roden, M. et al. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49, 701-707 (2000).
35. Williamson, J.R., Browning, E.T. & Scholz, R. Control mechanisms of gluconeogenesis and ketogenesis. I. Effects of oleate on gluconeogenesis in perfused rat liver. J. Biol. Chem. 244, 4607-4616 (1969).
36. Pocai, A., Obici, S., Schwartz, G.J. & Rossetti, L. A brain-liver circuit regulates glucose homeostasis. Cell Metab. 1, 53-61 (2005).
37. McKhann, G.M., D'Ambrosio, R. & Janigro, D. Heterogeneity of astrocyte resting membrane potentials and intercellular coupling revealed by whole-cell and gramicidin-perforated patch recordings from cultured neocortical and hippocampal slice astrocytes. J. Neurosci. 17, 6850-6863 (1997).
38. Dunn-Meynell, A.A., Rawson, N.E. & Levin, B.E. Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain. Brain Res. 814, 41-54 (1998).
39. Miki, T. et al. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat. Neurosci. 4, 507-512 (2001)
40. Vatamaniuk, M.Z., Horyn, O.V., Vatamaniuk, O.K. & Doliba, N.M. Acetylcholine affects rat liver metabolism via type 3 muscarinic receptors in hepatocytes. Life Sci. 72, 1871-1882 (2003).
41. Obici, S. et al. Central melanocortin receptors regulate insulin action. J. Clin. Invest. 108, 1079-1085 (2001).
42. Morton, G.J. et al. Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa(k)/fa(k)) rats. Endocrinology 144, 2016-2024 (2003).
43. Combs, T.P., Berg, A.H., Obici, S., Scherer, P.E. & Rossetti, L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 108, 1875-1881 (2001).
44. Hansen, A.M. et al. Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1. Diabetes 51, 2789-2795 (2002).
45. Tomoda, H., Igarashi, K., Cyong, J.C. & Omura, S. Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation. J. Biol. Chem. 266, 4214-4219 (1991).
46. Barzilai, N. et al. Leptin selectively decreases visceral adiposity and enhances insulin action. J. Clin. Invest. 100, 3105-3110 (1997).
47. la Fleur, S.E., Ji, H., Manalo, S.L., Friedman, M.I. & Dallman, M.F. The hepatic vagus mediates fat-induced inhibition of diabetic hyperphagia. Diabetes 52, 2321-2330 (2003).
48. Norgren, R. & Smith, G.P. A method for selective section of vagal afferent or efferent axons in the rat. Am. J. Physiol. 267, R1136-R1141 (1994).
49. Sclafani, A., Ackroff, K. & Schwartz, G.J. Selective effects of vagal deafferentation and celiac-superior mesenteric ganglionectomy on the reinforcing and satiating action of intestinal nutrients. Physiol. Behav. 78, 285-294 (2003).